investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Investigation of the ABC Half-Transporter ABCG2
Susan Bates
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
We aim to understand structure/function relationships in the ABC transporter ABCG2.
Related projects
Ana Soto
Mechanism of developmental toxicity of Bisphenol-A
Breast
Pathology
Vern L. Schramm
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
Breast
Matthew P Goetz
Mayo Clinic Breast Cancer SPORE
Breast
Pathology
Characterization of the Biological Activities of Novel Epigenetic Modulators
Trachea, bronchus and lung
Pathology
Carol A Lange
Inducible PTK6 expression drives oncogenic signaling in breast cancer
Breast
Shakti H Ramkissoon
ALK signaling in CNS development, ischemic brain injury and gliomagenesis
Brain, nervous system
Richard A Anderson
PI Signaling Role in Epithelial/Mesenchymal Transition
Breast
Robert A Gatenby
The Physical Microenvironment in Cancer Biology and Therapy
Brain, nervous system
Nathanael Schiander Gray
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Trachea, bronchus and lung